523 related articles for article (PubMed ID: 2543304)
1. [Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment].
Ohnoshi T; Hiraki S; Ueoka H; Kawahara S; Numata T; Nishii K; Yonei T; Yamashta H; Kiura K; Kozuka A
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1341-8. PubMed ID: 2543304
[TBL] [Abstract][Full Text] [Related]
2. [Progress and obstacles in chemotherapy and combined modality treatment of small cell lung cancer].
Ohnoshi T; Ueoka H; Numata T; Kawahara S; Nishii K; Yonei T; Mima Y; Horiguchi T; Kiura K; Moritaka T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):190-6. PubMed ID: 2162437
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
[TBL] [Abstract][Full Text] [Related]
4. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333
[TBL] [Abstract][Full Text] [Related]
5. [Pilot phase II study of hybrid chemotherapy of CAV-PVP in small cell lung cancer (SCLC)].
Ueoka H; Ohnoshi T; Hiraki S; Kawahara S; Numata T; Nishii K; Yonei T; Yamashita H; Moritaka T; Kiura K
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2251-5. PubMed ID: 2544149
[TBL] [Abstract][Full Text] [Related]
6. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
[TBL] [Abstract][Full Text] [Related]
7. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
[TBL] [Abstract][Full Text] [Related]
8. [Induction chemotherapy followed by adjuvant surgery (IC-AS) in patients with stage I-II small cell lung cancer (SCLC)].
Shibayama T; Hiyama J; Ueoka H; Tabata M; Segawa Y; Gemba K; Matsushita A; Ohnoshi T; Harada M; Andoh A
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1953-8. PubMed ID: 7487126
[TBL] [Abstract][Full Text] [Related]
9. [Cyclophosphamide, adriamycin and vincristine (CAV) in the treatment of small cell lung cancer].
Kawahara M; Tsuruta M; Furuse K; Arai R; Kodama N; Yamamoto M; Kubota K; Nakai R; Ogawara M
Gan To Kagaku Ryoho; 1988 Mar; 15(3):457-62. PubMed ID: 2831819
[TBL] [Abstract][Full Text] [Related]
10. Alternating chemotherapy with cyclophosphamide/adriamycin/vincristine (CAV) and cisplatin/etoposide (PVP) against small cell lung cancer. Eastern Shikoku Lung Cancer Chemotherapy Group.
Bando H; Takishita Y; Ogura T; Sone S; Shimizu E; Nakayama T; Doi H; Kobayashi M
Jpn J Clin Oncol; 1991 Dec; 21(6):435-9. PubMed ID: 1666660
[TBL] [Abstract][Full Text] [Related]
11. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial comparing chemotherapy alone and chemotherapy plus chest irradiation in limited stage small cell lung cancer: a preliminary report.
Ohnoshi T; Hiraki S; Kawahara S; Yamashita H; Yonei T; Ishii J; Egawa T; Kozuka A; Hiraki Y; Kimura I
Jpn J Clin Oncol; 1986 Sep; 16(3):271-7. PubMed ID: 3022036
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
Unsal M; Erturk D
Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Aisner J; Whitacre M; Van Echo DA; Wiernik PH
Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
[TBL] [Abstract][Full Text] [Related]
15. [The treatment of small cell lung cancer].
Li LY
Zhonghua Zhong Liu Za Zhi; 1992 Nov; 14(6):443-6. PubMed ID: 1338986
[TBL] [Abstract][Full Text] [Related]
16. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
[TBL] [Abstract][Full Text] [Related]
17. [Alternating chemotherapeutic treatment in patients with localized undifferentiated small-cell carcinoma of the lung].
Navarro M; Mur E; Jolis L; Bellmunt J; Bodi R; Solé LA; Rubio D
Rev Clin Esp; 1991 Oct; 189(5):209-12. PubMed ID: 1666192
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.
Schild SE; Bonner JA; Shanahan TG; Brooks BJ; Marks RS; Geyer SM; Hillman SL; Farr GH; Tazelaar HD; Krook JE; Geoffroy FJ; Salim M; Arusell RM; Mailliard JA; Schaefer PL; Jett JR
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):943-51. PubMed ID: 15234027
[TBL] [Abstract][Full Text] [Related]
19. Results of chemo-radiotherapy and prognostic factors of small cell lung cancer.
Shikaura S; Kawa S; Yoshida M; Yonezu S
Radiat Med; 1991; 9(2):70-6. PubMed ID: 1658856
[TBL] [Abstract][Full Text] [Related]
20. [Patterns of relapse in patients with small cell lung cancer--the effect of chest irradiation and prophylactic cranial irradiation combined with intensive chemotherapy on long-term survival].
Ueoka H; Ohnoshi T; Numata T; Kawahara S; Nishii K; Yonei T; Yamashita H; Moritaka T; Kiura K; Uji H
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1581-7. PubMed ID: 1963910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
